or Try an Advanced Search...

    Technical Analysis for GNPX - Genprex, Inc.

    Grade Last Price % Change Price Change
    F 2.20 -0.45% -0.01
    GNPX closed down 0.45 percent on Friday, May 24, 2024, on 38 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical GNPX trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish -0.45%
    Bollinger Band Squeeze Range Contraction -0.45%
    Earnings Movers Other -0.45%
    BB Squeeze + Lower Band Touch Range Contraction -0.45%
    Lower Bollinger Band Touch Weakness -0.45%
    20 DMA Resistance Bearish -7.17%
    Older End-of-Day Signals for GNPX ...

       Recent Intraday Alerts

    Alert Time
    Up 3% 4 days ago
    Up 2% 4 days ago
    Up 1% 4 days ago
    20 DMA Resistance 5 days ago
    Down 3% 5 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    GNPX Chart by TradingView
    Basic chart:

    Profile

    Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Biology Gene Therapy Medical Genetics Applied Genetics Medicinal Chemistry

    Is GNPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Genprex dosing subjects in trial of combination therapy for small-cell lung cancer
    May 14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
    May 9 Genprex co-founder, CEO passes away
    May 8 Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
    May 7 Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Apr 4 Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
    Apr 3 Genprex expands clinical trial sites for study to treat small cell lung cancer
    Apr 3 Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
    Apr 2 Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
    Mar 19 Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    See more GNPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.4
    52 Week Low 2.09
    Average Volume 42,281
    200-Day Moving Average 9.18
    50-Day Moving Average 2.63
    20-Day Moving Average 2.39
    10-Day Moving Average 2.40
    Average True Range 0.25
    RSI (14) 39.39
    ADX 12.83
    +DI 13.56
    -DI 17.65
    Chandelier Exit (Long, 3 ATRs) 1.98
    Chandelier Exit (Short, 3 ATRs) 2.85
    Upper Bollinger Bands 2.62
    Lower Bollinger Band 2.16
    Percent B (%b) 0.08
    BandWidth 19.01
    MACD Line -0.10
    MACD Signal Line -0.12
    MACD Histogram 0.0118
    Fundamentals Value
    Market Cap 3.27 Million
    Num Shares 1.49 Million
    EPS -24.40
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.42
    Resistance 3 (R3) 2.44 2.39 2.38
    Resistance 2 (R2) 2.39 2.33 2.38 2.37
    Resistance 1 (R1) 2.29 2.30 2.27 2.27 2.36
    Pivot Point 2.25 2.25 2.23 2.23 2.25
    Support 1 (S1) 2.15 2.19 2.13 2.13 2.04
    Support 2 (S2) 2.10 2.16 2.09 2.03
    Support 3 (S3) 2.01 2.10 2.02
    Support 4 (S4) 1.98